Page last updated: 2024-11-05

dodecylbenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Dodecylbenzene, also known as alkylbenzene, is a synthetic organic compound primarily used as a precursor to linear alkylbenzene sulfonate (LAS), a major component of household detergents. It is produced through the alkylation of benzene with dodecene, a process that typically involves Friedel-Crafts alkylation using a strong acid catalyst. The reaction results in a mixture of isomers, with the linear isomer being the most desirable due to its improved biodegradability. Dodecylbenzene's importance stems from its role in the production of LAS, which is a highly effective surfactant with excellent cleaning properties. However, there have been concerns regarding the environmental impact of LAS, particularly its potential bioaccumulation and persistence in the environment. Consequently, research efforts focus on developing more sustainable and biodegradable alternatives to LAS, with researchers exploring different alkylation processes and studying the environmental fate and effects of dodecylbenzene and its derivatives.'

Cross-References

ID SourceID
PubMed CID31237
CHEMBL ID3187866
MeSH IDM0123274

Synonyms (61)

Synonym
AKOS009031474
nsc-4584
nsc4584
n-dodecylbenzene
benzene, dodecyl-
dodecane, 1-phenyl-
wln: 12r
dodecylbenzene, crude
1-phenyldodecane
nsc102805
nsc-102805
marlican
phenyldodecan
dodecylbenzene
123-01-3
brn 1909107
laurylbenzene
phenyldodecan [german]
ai3-00435
hsdb 937
nsc 102805
ccris 2291
einecs 204-591-8
1-phenyldodecane, 97%
NCGC00164039-01
D1074
einecs 270-486-9
68442-69-3
25265-78-5
D0988
29986-57-0
NCGC00164039-02
4-05-00-01200 (beilstein handbook reference)
cas-123-01-3
dtxcid706994
tox21_303061
NCGC00256949-01
dtxsid7026994 ,
tox21_201344
NCGC00258896-01
unii-a2ax003680
dodecane, phenyl-
a2ax003680 ,
phenyldodecane
1-dodecylbenzene
FT-0631711
dodecyl-benzene
CHEMBL3187866
mfcd00008974
dodecylbenzene, hard type
1-dodecylbenzene; 1-phenyl-n-dodecane; 1-phenyldodecane
dodecane,phenyl-
1-phenyldodecane, analytical standard
Q414469
dodecylbenzene, hard type, mixture of isomers
BCP26389
MS-20701
1-phenyldodecane; laurylbenzene; n-dodecylbenzene
A877647
CS-0016030
benzene,tetrapropylene-

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"The adsorption of malachite green (MG) onto sodium dodecylbenzene sulfonate (SDBS)-modified sepiolite was investigated with respect to pH, oscillation rate, MG dosage and adsorbent dosage."( Adsorption of Malachite Green with Sodium Dodecylbenzene Sulfonate Modified Sepiolite: Characterization, Adsorption Performance and Regeneration.
Liu, B; Yu, J; Zhang, L, 2019
)
1.03
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency48.60710.003041.611522,387.1992AID1159552
retinoid X nuclear receptor alphaHomo sapiens (human)Potency21.48690.000817.505159.3239AID1159531
estrogen nuclear receptor alphaHomo sapiens (human)Potency33.25210.000229.305416,493.5996AID743069; AID743075
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency61.71270.001019.414170.9645AID743191
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency68.65940.011917.942071.5630AID651632
Ataxin-2Homo sapiens (human)Potency68.65940.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (18)

Processvia Protein(s)Taxonomy
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (10)

Processvia Protein(s)Taxonomy
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (21.05)18.7374
1990's2 (10.53)18.2507
2000's5 (26.32)29.6817
2010's4 (21.05)24.3611
2020's4 (21.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 74.40

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index74.40 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index124.07 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (74.40)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]